Day One Biopharmaceuticals Inc (NAS:DAWN)
$ 21.53 (0%) Market Cap: 2.22 Bil Enterprise Value: 1.79 Bil PE Ratio: 0 PB Ratio: 5.03 GF Score: 12/100

Day One Biopharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 01:15AM GMT
Release Date Price: $10.59 (-6.53%)
Anupam Rama
JPMorgan Chase & Co - Analyst

All right. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Joyce Zhou, Priyanka Grover, and Rati Pinge.

Our next presenting company is Day One. Presenting on behalf of the company, we have CEO, Jeremy Bender.

Jeremy Bender
Day One Biopharmaceuticals Inc - President, Chief Executive Officer, Director

Good afternoon, everybody. Thank you, Anupam, and thanks to the JPMorgan team for the opportunity to be here today. I also welcome all of you in the audience as well as those listening in. My name is Jeremy Bender. I'm CEO of Day One Biopharmaceuticals.

Excited for the opportunity to tell you about the company today. Joining me are a few colleagues, Lauren Merendino, our CCO; Charles York, our COO and CFO; and Mike Vasconcelles, our Head of R&D. A quick reminder that I will be making forward-looking statements during the presentation today.

We at Day One,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot